ArticleOncology letters2026
Adrenal lymphoma with hypertension: A report of three cases.
Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adrenal lymphoma is a rare clinical entity, classified as either primary adrenal lymphoma (PAL) or secondary adrenal lymphoma. PAL is a highly aggressive malignancy with an extremely low incidence rate. To date, <250 cases have been reported in the English literature. The clinical manifestations of PAL are diverse and non-specific, often resulting in a delayed diagnosis or a misdiagnosis. In patients with comorbid hypertension, the differential diagnosis of an adrenal mass typically emphasizes functional tumors, such as aldosterone-producing tumors (which cause primary aldosteronism) and pheochromocytoma. Due to the usual absence of characteristic hormonal abnormalities, PAL is frequently overlooked in clinical practice. The present report describes the cases of 3 male patients with PAL, aged 83, 73 and 63 years. The first 2 patients had pre-existing hypertension prior to the confirmation of PAL. The present report summarizes the diagnostic strategies for PAL and relevant differential diagnoses, and describes the treatment responses observed in each case. Diagnosing PAL is challenging, and its prognosis is generally poor. PAL should be considered in the differential diagnosis of adrenal masses, particularly in patients with a history of hypertension. Once diagnosed, management should be guided by a multidisciplinary team specialized in adrenal and hematological disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.